The Definitive Guide for Cannabidiolo - Tom Hemps

Ames, F. R. and Cridland, S. Anticonvulsant result of cannabidiol. S.Afr. Med. J. 1-4-1986; 69( 1 ):14. View abstract. Barnes, M. P. Sativex: medical effectiveness and tolerability in the treatment of symptoms of several sclerosis and neuropathic discomfort. Expert. Opin. Pharmacother. 2006; 7( 5 ):607 -615. View abstract. Carlini, E. A. and Cunha, J. M. Hypnotic and antiepileptic results of cannabidiol.

View abstract. Collin, C., Davies, P., Mutiboko, I. K., and Ratcliffe, S. Randomized controlled trial of cannabis-based medicine in spasticity brought on by multiple sclerosis. Eur. J.Neurol. 2007; 14( 3 ):290 -296. View abstract. Collin, C., Ehler, E., Waberzinek, G., Alsindi, Z., Davies, P., Powell, K., Notcutt, W., O'Leary, C., Ratcliffe, S., Novakova, I., Zapletalova, O., Pikova, J., and Ambler, Z.

Neurol. Res. 2010; 32( 5 ):451 -459. View abstract. Consroe, P., Kennedy, K., and Schram, K. Assay of plasma cannabidiol by capillary gas chromatography/ion trap mass spectroscopy following high-dose repeated daily oral administration in people. Pharmacol Biochem. Behav. 1991; 40( 3 ):517 -522. View abstract. Consroe, P., Laguna, J., Allender, J., Snider, S., Stern, L., Sandyk, R., Kennedy, K., and Schram, K.

Pharmacol Biochem. Behav. 1991; 40( 3 ):701 -708. View abstract. Cunha, J. M., Carlini, E. A., Pereira, A. E., Ramos, O. L., Pimentel, C., Gagliardi, R., Sanvito, W. L., Lander, N., and Mechoulam, R. Persistent administration of cannabidiol to healthy volunteers and epileptic clients. Pharmacology 1980; 21( 3 ):175 -185. View abstract. Harvey, D. J., Samara, E., and Mechoulam, R.

Pharmacol Biochem. Behav. 1991; 40( 3 ):523 -532. View abstract. Iuvone, T., Esposito, G., Esposito, R., Santamaria, R., Di Rosa, M., and Izzo, A. A. Neuroprotective effect of cannabidiol, a non-psychoactive element from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells. J Neurochem. 2004; 89( 1 ):134 -141. View abstract. Ohlsson, A., Lindgren, J. E., Andersson, S., Agurell, S., Gillespie, H., and Hollister, L.

Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration. Biomed. Environ Mass Spectrom. 1986; 13( 2 ):77 -83. View abstract. Srivastava, M. D., Srivastava, B. I., and Brouhard, B. This Article Is More In-Depth and cannabidiol alter cytokine production by human immune cells. Immunopharmacology 1998; 40( 3 ):179 -185. View abstract. Trembly B, Sherman M. Double-blind scientific study of cannabidiol as a secondary anticonvulsant.

Wade, D. T., Collin, C., Stott, C., and Duncombe, P. Meta-analysis of the efficacy and security of Sativex (nabiximols), on spasticity in individuals with multiple sclerosis. Mult. Scler. 2010; 16( 6 ):707 -714. View abstract. Wade, D. T., Makela, P., Robson, P., Home, H., and Bateman, C. Do cannabis-based medical extracts have general or particular effects on signs in numerous sclerosis? A double-blind, randomized, placebo-controlled research study on 160 patients.